On October 12 to 14, 2021, the 2021 China International Pharmaceutical API/Intermediate/Packaging/Equipment Trade Fair (API China for short) was held in Wuhan International Expo Center. Founded in 1968, API China focuses on improving the overall level of production, R&D of Chinese medicine active pharmaceutical ingredients (APIs), intermediates and pharmaceutical excipients, and represents new products and technologies in China’s pharmaceutical industry. It has become the brand event that gathers industry leaders, displays advanced products and technologies, improves industry level and reflects industry trends. API China has been supported by more than 97% of top 100 enterprises in China’s pharmaceutical industry, provided opportunities for the decision-makers, purchasing personnel, technicians and R&D personnel of pharmaceutical enterprises to communicate and cooperate with the target customers.

As a key pharmaceutical enterprise in the Cephalosporin industry, Titan Pharmaceutical was invited to participate in the fair, focusing on Cefuroxime sodium, Cefuroxime axetil and other products. During the exhibition, the booth of Titan Pharmaceutical was crowded all the time. The core management team of the company communicated with customers and talked about the market situation and product prospects, with some new customers exploring space for product development and cooperation. Taking this opportunity, Titan Pharmaceutical further enhanced links with customers and created a good atmosphere for mutual trust and cooperation. While realizing all-round display of products and comprehensive communication with customers, the company also had a better understanding of customers and market demands through this fair, which provides new ideas for the company to meet the customer demands and develop new products in future.